Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €2,049 | €833 | €1,066 | €608 |
| - Cash | €90 | €117 | €123 | €15 |
| + Debt | €268 | €261 | €257 | €317 |
| Enterprise Value | €2,228 | €977 | €1,201 | €909 |
| Revenue | €225 | €207 | €187 | €167 |
| % Growth | 8.3% | 10.9% | 12% | – |
| Gross Profit | €139 | €47 | €179 | €138 |
| % Margin | 62% | 22.7% | 95.5% | 82.5% |
| EBITDA | €58 | €45 | €40 | €62 |
| % Margin | 25.6% | 21.9% | 21.6% | 37.2% |
| Net Income | €28 | €28 | -€1 | €8 |
| % Margin | 12.4% | 13.4% | -0.3% | 5% |
| EPS Diluted | 0.55 | 0.65 | -0.045 | 0.085 |
| % Growth | -15.4% | 1,544.4% | -153.1% | – |
| Operating Cash Flow | €45 | €47 | €22 | €21 |
| Capital Expenditures | -€21 | -€23 | -€9 | -€16 |
| Free Cash Flow | €24 | €24 | €13 | €5 |